Esophagogastric junction adenocarcinomas: individualization of resection with special considerations for Siewert type II, and Nishi types EG, E=G and GE cancers Arnulf H. HölscherSimon Law Review Article 06 November 2019 Pages: 3 - 9
Correction to: Esophagogastric junction adenocarcinomas: individualization of resection with special considerations for Siewert type II, and Nishi types EG, E = G and GE cancers Arnulf H. HölscherSimon Law Correction 12 December 2019 Pages: 10 - 10
Peritoneal metastasis in gastric cancer: results from the German database Beate RauAndreas Brandlfor the Peritoneum Surface Oncology Group and members of the StuDoQ|Peritoneum Registry of the German Society for General and Visceral Surgery (DGAV) Original Article 21 June 2019 Pages: 11 - 22
IGF2-AS affects the prognosis and metastasis of gastric adenocarcinoma via acting as a ceRNA of miR-503 to regulate SHOX2 Ju HuangYou-xiang ChenBo Zhang Original Article 10 June 2019 Pages: 23 - 38
Targeting the WEE1 kinase strengthens the antitumor activity of imatinib via promoting KIT autophagic degradation in gastrointestinal stromal tumors Weizhen LiuXiangyu ZengPeng Zhang Original Article 13 June 2019 Pages: 39 - 51
A genetic origin for acid–base imbalance triggers the mitochondrial damage that explains the autoimmune response and drives to gastric neuroendocrine tumours Javier BenÃtezRoberta MarraOriol Calvete Original Article 27 June 2019 Pages: 52 - 63
Hedgehog signalling pathway activation in gastrointestinal stromal tumours is mediated by primary cilia Pablo IruzubietaMarta MonzónConcepción Junquera Original Article 02 July 2019 Pages: 64 - 72
Infiltrating and peripheral immune cell analysis in advanced gastric cancer according to the Lauren classification and its prognostic significance Simon PernotMagali TermeJulien Taieb Original Article 02 July 2019 Pages: 73 - 81
Cancer neovasculature-targeted near-infrared photoimmunotherapy (NIR-PIT) for gastric cancer: different mechanisms of phototoxicity compared to cell membrane-targeted NIR-PIT Takashi NishimuraMakoto MitsunagaMasayuki Saruta Original Article 13 July 2019 Pages: 82 - 94
Prognostic impacts of the combined positive score and the tumor proportion score for programmed death ligand-1 expression by double immunohistochemical staining in patients with advanced gastric cancer Kohei YamashitaMasaaki IwatsukiHideo Baba Original Article 26 August 2019 Pages: 95 - 104
Epigenetic priming sensitizes gastric cancer cells to irinotecan and cisplatin by restoring multiple pathways Hiroshi MoroNaoko HattoriToshikazu Ushijima Original Article 25 September 2019 Pages: 105 - 115
Correction to: Epigenetic priming sensitizes gastric cancer cells to irinotecan and cisplatin by restoring multiple pathways Hiroshi MoroNaoko HattoriToshikazu Ushijima Correction 15 November 2019 Pages: 116 - 117
Adherence to the guidelines and the pathological diagnosis of high-risk gastrointestinal stromal tumors in the real world Toshirou NishidaYoshiharu SakaiThe members of the STAR ReGISTry Study Group Original Article Open access 30 April 2019 Pages: 118 - 125
Convolutional neural network for the diagnosis of early gastric cancer based on magnifying narrow band imaging Lan LiYishu ChenChaohui Yu Original Article Open access 22 July 2019 Pages: 126 - 132
Developing real-world comparators for clinical trials in chemotherapy-refractory patients with gastric cancer or gastroesophageal junction cancer Ian ChauDung T. LeTong Shangguan Original Article Open access 23 September 2019 Pages: 133 - 141
Correction to: Developing real-world comparators for clinical trials in chemotherapy-refractory patients with gastric cancer or gastroesophageal junction cancer Ian ChauDung T. LeTong Shangguan Correction Open access 03 November 2019 Pages: 142 - 142
Exploratory subgroup analysis of patients with prior trastuzumab use in the ATTRACTION-2 trial: a randomized phase III clinical trial investigating the efficacy and safety of nivolumab in patients with advanced gastric/gastroesophageal junction cancer Taroh SatohYoon-Koo KangNarikazu Boku Original Article Open access 13 May 2019 Pages: 143 - 153
Clinical outcomes of non-exposed endoscopic wall-inversion surgery for gastric submucosal tumors: long-term follow-up and functional results Junya AoyamaOsamu GotoYuko Kitagawa Original Article 03 July 2019 Pages: 154 - 159
Meta-analysis of two randomized phase III trials (TCOG GI-0801 and ECRIN TRICS) of biweekly irinotecan plus cisplatin versus irinotecan alone as second-line treatment for advanced gastric cancer Kazuhiro NishikawaWasaburo KoizumiJunichi Sakamoto Original Article 15 July 2019 Pages: 160 - 167
Factors associated with technical difficulty of endoscopic submucosal dissection for early gastric cancer that met the expanded indication criteria: post hoc analysis of a multi-institutional prospective confirmatory trial (JCOG0607) Tomonori YanoNoriaki HasuikeManabu Muto Original Article 18 July 2019 Pages: 168 - 174
Survival after neoadjuvant approaches to gastroesophageal junction cancer Michael XiangDaniel T. ChangErqi L. Pollom Original Article 22 June 2019 Pages: 175 - 183
Laparoscopic total gastrectomy for upper-middle advanced gastric cancer: analysis based on lymph node noncompliance Qi-Yue ChenGuang-Tan LinChang-Ming Huang Original Article 12 July 2019 Pages: 184 - 194
Different risks of nodal metastasis by tumor location in remnant gastric cancer after curative gastrectomy for gastric cancer Kazuya TakahashiTakaki YoshikawaHitoshi Katai Original Article 13 July 2019 Pages: 195 - 201